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Abstract
Purpose
Plant-derived oleanolic acid (OA) and its related synthetic derivatives (Br-OA and Me-OA)
possess antihypertensive effects in experimental animals. The present study investigated
possible underlying mechanisms in rat isolated single ventricular myocytes and in vascular
smooth muscles superfused at 37°C.
Methods
Cell shortening was assessed at 1 Hz using a video-based edge-detection system and the
L-type Ca2+ current (ICaL) was measured using the whole-cell patch-clamp technique in sin-
gle ventricular myocytes. Isometric tension was measured using force transducer in isolated
aortic rings and in mesenteric arteries. Vascular effects were measured in endothelium-
intact and denuded vessels in the presence of various enzyme or channel inhibitors.
Results
OA and its derivatives increased cell shortening in cardiomyocytes isolated from normoten-
sive rats but had no effect in those isolated from hypertensive animals. These triterpenes
also caused relaxation in aortic rings and in mesenteric arteries pre-contracted with either
phenylephrine or KCl-enriched solution. The relaxation was only partially inhibited by endo-
thelium denudation, and also partly inhibited by the cyclooxygenase (COX) inhibitor indo-
methacin, with no additional inhibitory effect of the NO synthase inhibitor, N-ω-Nitro-L-
arginine. A combination of both ATP-dependent channel inhibition by glibenclaminde and
voltage-dependent K+ channel inhibition by 4-aminopyridine was necessary to fully inhibit
the relaxation.
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Conclusion
These data indicate that the effects of OA and its derivatives are mediated via both endothe-
lium-dependent and independent mechanisms suggesting the involvement of COX in the
endothelium-dependent effects and of vascular muscle K+ channels in the endothelium-
independent effects. Finally, our results support the view that the antihypertensive action of
OA and its derivatives is due to a decrease of vascular resistance with no negative inotropic
effect on the heart.
Introduction
Hypertension is a highly prevalent cardiovascular condition and constitutes a major risk factor
for other cardiovascular diseases [1]. Cardiovascular-related mortality and morbidity pose a
heavy burden on health systems, especially in conditions of limited resources in low and mid-
dle-income countries [2]. Although there are currently many effective anti-hypertensive drugs,
these remain relatively inaccessible to the poor communities due to high cost, especially since
the majority of the patients require more than one therapeutic drug. There is, therefore, a need
to find cheaper therapeutic alternatives. Plant-derived extracts have been used as therapeutic
agents for hundreds of years by many cultures because of their accessibility [3–5]. However,
research is needed to validate the efficacy and the action mechanisms of these plant extracts,
including those with beneficial effects on hypertension. There is great interest in plant derived
triterpenes, including oleanolic acid (OA), which possess multiple beneficial systemic (antiin-
flammatory, immunomodulatory, antitumor, antidegenerative, antidiabetic) or organ-specific
(renoprotective, cardioprotective, hepatoprotective) effects (for references see [6]). We have
previously demonstrated that Syzygium aromaticum-derived oleanolic acid (OA) and related
triterpene derivatives possess antihypertensive effects in experimental models of hypertensive
animals [7, 8]. In particular, we have shown that these triterpenes have marked natriuretic and
antioxidant actions, particularly in Dahl-salt sensitive (DSS) and spontaneously hypertensive
rats (SHR) [8]. The natriuretic action was not accompanied by an effect on diuresis, excluding
any effect on intravascular filling. Hence, the interest of this study was to further investigate the
mechanisms of blood pressure-lowering properties of OA and related oleanane derivatives,
and more specifically to examine potential cardiac and vascular effects.
Vascular smooth muscle contraction and relaxation result from the increased phosphoryla-
tion and dephosphorylation, respectively, of myosin light chains. Increased phosphorylation is
mediated by the increased activity of a calmodulin-dependent myosin light chain kinase
(MLCK) and by the decreased activity of phosphatases (PP). This occurs following the increase
of the cytosolic Ca2+ concentration ([Ca2+]c) either upon opening of sarcolemmal Ca
2+ chan-
nels by membrane depolarization or upon Ca2+release from intracellular stores following the
formation of inositol-triphosphate (IP3) by agonists coupled to phospholipase C. Hyperpolari-
zation following the opening of various types of K+ channels causes relaxation by deactivating
the Ca2+ channels, and the role of K+ channels in relaxation can be tested using K+ channels
blockers. MLCK or PP enzyme activities and hence smooth muscle contraction can also be
modulated by various signaling pathways, including those involving intracellular nucleotides
(such increases of intracellular cGMP or cAMP, mediated by NO and by cyclooxygenase
(COX) products, respectively) but also nucleotide-independent cascades. The role of these
pathways can be tested by inhibiting key enzymes involved in the signaling cascade.
The aim of our study was to examine the possible role of cardiac negative inotropic and/or
vasculo-relaxant effects of OA and derivatives as mechanisms underlying the blood pressure-
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lowering properties of these agents. In particular, we wanted to examine the pathways impli-
cated in these effects. Therefore we tested the role of ATP-dependent potassium channels in
OA and derivative-induced relaxation using glibenclamide, and that of voltage-dependent
channels using 4-amino-pyridine. NO formation was blocked by a non-specific NO synthase
(NOS) inhibitor, and COX was inhibited by indomethacin.
Materials and Methods
Chemicals
OA (C30H47O3) was isolated from Syzygium aromaticum [(Linnaeus) Merrill & Perry] (Myrta-
ceae) (cloves) and its methyl ester (Me-OA; C31H50O3) and brominated (Br-OA; C31H43BrO4)
derivatives were synthesized as described previously [8]. Stock solutions of these drugs were
prepared in DMSO and were diluted to the final experimental concentration (0.1 μM-1 mM)
by dissolving in the cell or tissue superfusing solutions (see below).
Animals
Male Wistar and Dahl salt-sensitive (DSS) rats (250–300 g) were purchased from Charles River
Laboratories Inc. (Wilmington, MA, United States of America) and housed in the Animalium
of the University of Leuven. The rats were maintained on a 12 h light / dark regime and had
free access to both food and water. The DSS rats were fed high salt Na+ diet (8%) (Bio Services,
Berlin, Germany) from the age of 4 up to 10 weeks. All experimental protocols were reviewed
and approved by animal ethics committees of KULeuven (4500768204) and UCL (2012/MD/
UCL/004).
Cardiac cell and vascular tissue isolation
Ventricular cardiomyocyte isolation. The methods for cell dissociation and electrophysi-
ological measurements were similar to those described previously [9]. Briefly, rats were injected
with heparin (70–85 mg kg-1 i.p) 10 min before sacrifice, and they were euthanized by injection
with pentobarbital (150–300 mg kg-1 i.p). The chest was cut open and the heart immediately
removed and placed in ice-cold cardioplegic solution containing 27 mM KCl and 50 mM glu-
cose to arrest contraction and protect against metabolic consequences of hypoxia during can-
nulation of the aorta. The heart was then mounted on the perfusion system and was initially
perfused with normal Tyrode solution of the following composition in mM: 135 NaCl, 5.4 KCl,
1.8 CaCl2, 0.9 MgCl2, 10 HEPES, with pH 7.45 to test its functional state and wash out the
remaining blood. Cell dissociation involved 1) perfusion with Ca2+-free Tyrode for 5–10 min,
2) perfusion with Ca2+-free Tyrode containing collagenase A (0.4–0.5 mg mL-1, Roche Diag-
nostics, Germany) and protease (type XIV 0.08 mg mL-1, Sigma, USA) to digest the extracellu-
lar matrix, 3) perfusion with Ca2+-free Tyrode containing collagenase A (without added
protease), 4) perfusion with Ca2+-and enzyme-free solution to stop the enzyme digestion, and
5) perfusion with Tyrode solution into which Ca2+ was gradually reintroduced up to a concen-
tration of 0.18 mM. The ventricles were cut out into the latter solution and cells were dissoci-
ated by gentle mechanical agitation and filtered through a mesh (200 μm hole diameter). Cells
were given time to settle down at room temperature before use for measurements.
Vascular tissue isolation. The methods for vascular tissue isolation, contraction and
relaxation measurements were similar to those described previously [10]. Briefly, male Wistar
and DSS rats (250 g) were sacrificed by stunning and exsanguination. Aorta or small, 2nd or 3rd
branches of mesenteric arteries (SMA) were quickly removed and immersed in physiological
saline solution (PSS) of the following composition in mM: 120 NaCl, 5.9 KCl, 25 NaHCO3,
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11.5 glucose, 1.2 NaH2PO4, 1.2 MgCl2 and 2.5 CaCl2. Arteries were cleaned of all fat and con-
nective tissue. All dissection procedures were carefully done to protect the functional endothe-
lium from damage. Each aortic or mesenteric segment was cut with a sterile dissection scissor
into rings of approximately 1.5–2 mm width. Endothelium denuded aortic rings and SMA
were obtained by gently rubbing the lumen of the artery with forceps tip or with hair,
respectively.
Measurements
Cell shortening in cardiac myocytes. Cells were placed in a chamber mounted on the
stage of an inverted microscope (Olympus X-70) and superfused with Tyrode solution at 35°C.
The cells were field-stimulated with 2.5 ms pulses at a frequency of 1 Hz (Myopacer Cell Stimu-
lator, IonOptix, Milton, USA). A video-based edge detector (Crescent, Salt Lake City, USA)
was used to capture and convert changes in cell length during contraction and relaxation into
an analog voltage signal. Tyrode solution containing OA or derivatives was superfused at dif-
ferent time intervals during the experimental period. The magnitude of cell contraction was
assessed by measuring the amplitude of cell shortening, the kinetics of contraction develop-
ment by measuring the time-to-peak contraction (TTP) and the kinetics of relaxation by mea-
suring the time constant (tau) of the late, exponential relengthening. Cell contraction is
expressed as percentage shortening relative to the resting cell length.
Ca2+ current measurements. In a few cells, preliminary studies were carried out to exam-
ine whether the inotropic effects of the drugs could be accounted for by an effect on the L-type
Ca2+ current (ICaL). For this purpose, whole cell currents were recorded with the patch-clamp
technique at room temperature using patch pipettes pulled from capillary glass (GB 200-8P;
Science Products, Hofheim, Germany) on a DMZ Universal Puller (Zeitz-Instrumente,
Munich, Germany), with a final resistance of 2–4 MO when filled with internal solution of the
following composition in mM: 130 CsCl, 25 TEA-Cl, 1 MgCl2, 5 Na2ATP, 0.1 Na2GTP, 1
EGTA, 5 HEPES, pH adjusted to 7.25 with CsOH. The voltage-clamp protocol consisted of a
pre-step from the holding potential of -70 mV to -50 mV to inactivate voltage-dependent Na+
channels, followed by 200 ms depolarizing voltage steps to various levels between -40 and
+70 mV to activate ICa. In these experiments, the cells were superfused and internally dialyzed
with Cs-based solutions in order to block K+ currents [9].
Isometric tension and vasodilatory effects. Aortic rings were mounted under a tension of
20 mN in a 12.5 mL organ-bath. Mesenteric arteries were mounted in a wire myograph (DMT,
Aarhus, Denmark) under the tension determined by the normalization procedure [11] in a
6 mL organ bath. The baths were perfused with PSS and gassed with 95% O2 and 5% CO2 at
37°C. Artery rings were first stimulated with low-NaCl high-KCl PSS of the following composi-
tion in mM: 31.9 NaCl, 94 KCl, 25 NaHCO3, 11.5 glucose, 1.2 NaH2PO4, 1.2 MgCl2 and 2.5
CaCl2 in order to assess vessel integrity. A washout and recovery period of 15 min was allowed
before starting the experiment.
Aortic rings and SMA with and without functional endothelium were pre-contracted with a
single sub-maximal concentration of KCl (50 mM) or phenylephrine (PE; 5 μM). When a sus-
tained and stable contraction was observed, cumulative concentration-response effects were
measured upon sequential exposure to carbachol (CCh; 0.01–100 μM), to test the presence of a
functional endothelium, or to OA and derivatives (0.1 μM-1 mM). Endothelium-denuded ves-
sels were recognized by the absence of a significant response to the addition of CCh (residual
contraction larger than 90% of the maximum contraction). Each drug concentration was left in
contact with the vessels for 2 min. The contractile tension was measured using data acquisition
hardware and software (Myodacq 2.01, DMT, Aarhus, Denmark). Following each
Vascular and Cardiac Effects of Oleanolic Acid and Its Synthetic Oleanane Derivatives
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concentration-response curve the vessels were washed with PSS and let to recover in PSS for 15
min. The involvement of NO and/or COX in triterpene-induced effects was examined in intact
aortic rings and SMA pre-treated with N-ω-Nitro-L-arginine (L-NoARg; 100 μM) a NOS
inhibitor, and/or with indomethacin (INDO; 10 μM), a non-selective COX inhibitor for 30
minutes. To assess a possible involvement of K+ channels in the effects of OA and derivatives,
isolated vessels were pretreated with the ATP-dependent K+ channel blocker glibenclamide
(Gli, 5 mM) or/and with the voltage-activated K+ channel blocker 4-aminopyridine (4-AP;
1 mM). The drug concentrations used cause maximal blockade of the targeted channels.
Data analysis
Data analysis for cardiac studies was performed using Clampfit 8.2 (Axon Instruments, Scot-
land) and Origin (Origin lab, USA). Differences between groups were analyzed for statistical
significance using ANOVA with a Fisher post-hoc test, using Statistica 7.1 (StatSoft, USA).
Vascular studies data were analyzed using GraphPad InStat (version 5.00, GraphPad Software,
San Diego, CA, USA). Statistical comparison of the differences between the control and experi-
mental groups was performed with a two-way analysis of variance, followed by a Bonferroni
multiple comparison test. All data are expressed as mean ± standard error of the mean (SEM).
When comparing data, a difference with p< 0.05 was considered as significant.
Results
Effects on cardiomyocyte shortening
Fig 1 illustrates the effects of OA, Br-OA and Me-OA (each at 160 μM) on cell shortening mea-
sured at 1 Hz in cardiomyocytes from control, non-hypertensive Wistar rats and from DSS
hypertensive rats. Superfusion with Tyrode containing OA, Br-OA or Me-OA increased the
shortening amplitude of cells isolated fromWistar rats (Fig 1, tracings in left panels). The
effects were reversible, at least in part, during the drug washout period. OA and derivatives had
no significant effect on cell shortening in cells isolated from DSS rats (Fig 1, tracings in right
panels).
Pooled summary data are presented in the lower parts of each panel of Fig 1. Beside peak
amplitudes (left column graph of each panel), kinetic parameters, namely the time-to-peak
(middle column graph of each panel) and the time constant of the late relaxation phase (right
column graph of each panel), were also measured. It is to be noted that there were marked dif-
ferences in these kinetic parameters between ventricular myocytes fromWistar rats and those
from DSS rats. Time to peak (TTP) and relaxation time constants were significantly
(p< 0.0001) increased in cells from the hypertensive animals compared to the cells from nor-
motensive Wistar rats. OA and its derivatives had no effects on these kinetics parameters, even
in cells fromWistar rats where contraction amplitude increased.
A few preliminary experiments were conducted to test whether an increase in Ca2+ currents
can account for the positive inotropic effect observed in Wistar rats. In ventricular myocytes
(n = 6), OA had no significant effects on the Ca2+ current measured using the whole-cell
patch-clamp technique (at 0 mV: control 591.0 ±36.55 pA vs OA 556.4 ±32.60 pA).
Because of the above findings further work focused on vascular effects.
Effects on vascular smooth muscles
The potential vasodilating properties of OA and derivatives was evaluated in rat aortic rings
(mounted in classical organ baths) and in 2nd to 3rd order mesenteric arteries (mounted in
wire-myographs). Experiments were performed in endothelium-intact and denuded vessels to
Vascular and Cardiac Effects of Oleanolic Acid and Its Synthetic Oleanane Derivatives
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Fig 1. Cell contraction measured under control conditions, during drug treatment and during drug
washout in ventricular myocytes fromWistar and DSS rats.Cells were superfused with Tyrode solution
containing OA, Me-OA and Br-OA (160 μmol L-1) during the treatment period. Original tracings of cell
Vascular and Cardiac Effects of Oleanolic Acid and Its Synthetic Oleanane Derivatives
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discriminate between endothelium-dependent and -independent mechanisms, or in the pres-
ence of various inhibitors to determine the signaling pathways or effectors involved.
Comparison of the vasodilating effects of OA and derivatives. Addition of OA, Me-OA
or Br-OA on endothelium-intact mesenteric arteries pre-contracted with KCl-enriched solu-
tion (Fig 2A and 2C) or PE (Fig 2B) evoked a significant relaxation of the arterial segments iso-
lated fromWistar rats. Similarly, these drugs also induced relaxation in aortic rings (Fig 2D
and 2E), but the effects were clearly less marked than in the mesenteric arteries (e.g. p< 0.001,
for the maximum relaxation evoked by Br-OA in PE pre-contracted mesenteric vessels vs aorta
vessels; p< 0.001 for KCl pre-contracted arteries). When comparing the effects of the three
drugs, Br-OA showed a significantly larger maximum relaxation than OA and Me-OA. This
difference, however, was not apparent in the aortic rings.
A similar pattern in relaxation with all the three drugs was observed in arterial segments iso-
lated from DSS rats (Fig 3). There was no difference in the magnitude of relaxant effects of OA
and derivatives in Wistar and DSS isolated vessels (e.g. % residual contraction of PE-precon-
traction of mesenteric arteries 22.03 ±3.43% in Wistar vs. 31.13 ±7.33% in DSS and aortic rings
62.83 ±7.26% in Wistar vs. 63.89 ±4.88% in DSS with 10−3 M Br-OA; n = 7; p> 0.05). Further
experiments to evaluate the mechanisms of vasorelaxation properties of OA and derivatives
were conducted in arterial segments isolated fromWistar rats only.
Endothelium-dependent vasorelaxant effects of OA and derivatives. The relaxation
evoked by OA and derivatives was only partially inhibited in the absence of functional endo-
thelium as shown in endothelium-denuded vascular rings experiments (Fig 4, shown only for
Br-OA, p< 0.05 for mesenteric vessels; p< 0.001 for aorta; results for OA and Me-OA pre-
sented in S1 and S2 Figs respectively). This indicates that the relaxation-evoked by OA or
derivatives involves both endothelium-dependent and independent mechanisms.
In order to characterize the endothelium-dependent relaxation, endothelium-intact vessels
were incubated in the presence of the COX inhibitor INDO or of the NOS inhibitor L-NoArg.
As shown in Fig 4, incubation with INDO blocked Br-OA-evoked relaxation to the same extent
as removal of the endothelium (p< 0.05 for absence vs. presence of INDO in mesenteric arter-
ies; p< 0.001 for aorta). Addition of L-NoArg did not further inhibit the COX-resistant relaxa-
tion. Qualitatively similar results were observed with OA and Me-OA (see S1 and S2 Figs). In a
limited number of experiments, vessels were exposed to L-NoArg in the absence of INDO (see
S1 Table) without any significant inhibition of the relaxation to OA or derivatives. These data
are in favor of an involvement of COX and prostanoids-dependent mechanisms, and against
the implication of NOS/NO-dependent pathways.
Endothelium-independent vasorelaxant effects of OA and derivatives. As observed
above (Fig 4), a significant portion of the relaxation evoked by OA and derivatives is resistant
to removal of the endothelium suggesting a role of endothelium-independent pathways. To
investigate the possible involvement of K+ channels, denuded vessels were incubated in the
presence of glibenclamide (Gli) to block ATP-dependent K+ channels, and of 4-aminopyridine
(4-AP) to block voltage-activated K+ channels. Fig 5 shows that either inhibitor when applied
alone was able to block part of the relaxation evoked by Br-OA. The effects of both inhibitors
were additive since concomitant application of both blockers allowed a complete inhibition of
shortening fromWistar (left panels) and DSS rats (right panels) are displayed in A (for OA), E (for Me-OA) and
I (for Br-OA). Amplitudes of cell shortening (B, F and J), time to peak shortening (C, G and K) and time
constant of relaxation (tau; D, H and L) were measured fromWistar (unfilled columns) and DSS rats (stripped
columns) at 1 Hz stimulation frequency (n = 6) for each drug. C: control, OA: oleanolic acid, Me: methylated
derivative, Br: brominated derivative, W: washout. * p < 0.001 for drug vs control (short horizontal bars),
** p < 0.0001 for Wistar vs DSS (long horizontal bars).
doi:10.1371/journal.pone.0147395.g001
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the relaxation caused by Br-OA. The endothelium-independent relaxation evoked by OA and
Me-OA was also completely blunted by Gli and 4-AP (see S3 and S4 Figs respectively). Experi-
ments performed with endothelium-intact vessels incubated with a cocktail of INDO, 4-AP
and Gli did not show any relaxation upon addition of Br-OA as shown in Fig 6 (illustrated for
Fig 2. OA and derivatives evoke a vasodilation in aorta andmesenteric arteries fromWistar rats.Original tracing [A] for Br-OA in mesenteric arteries
precontracted with KCl. Concentration-response curves for solvent, OA, Me-OA, and Br-OA in endothelium-intact mesenteric arteries [B, C] or aortic rings
[C, D] isolated fromWistar rats, pre-contracted with sub-maximal concentration of PE (5 μM) [A, C] and KCl (50 mM) [B, D]. The values shown are
means ± SEM (n = 7). * p < 0.001 vs control, # vs Br-OA.
doi:10.1371/journal.pone.0147395.g002
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OA and Me-OA in S5 and S6 Figs respectively). These data suggest that ATP-dependent and
voltage-activated K+ channels opening mediate the endothelium independent relaxation.
Discussion
The present study was carried out to further investigate the mechanisms of blood pressure low-
ering effects of OA and related synthetic derivatives. Previous studies have documented a
marked natriuretic action of these drugs in vivo [7, 8, 12]. The present study shows that OA
and synthetic derivatives do not decrease but rather increase myocyte shortening in cells iso-
lated from normotensive rats but not in cells isolated from hypertensive animals. The study
also confirms previous observations that OA possesses vasorelaxant properties in the aorta and
in mesenteric arteries [13, 14], and extend these properties to the two synthetic derivatives, Br-
OA and Me-OA.
Cardiac function is one of the factors that regulate mean arterial pressure (MAP), and an
effect on the heart, such as a decrease of the heart rate or of the stroke volume, could also con-
tribute to the blood pressure lowering effect of OA and its derivatives. No or mild effects on
heart rate have been reported for the compounds in previous studies [15, 16], indicating that
bradycardia cannot account for the marked decrease in MAP obtained with the drugs. In the
Fig 3. OA and derivatives evoke a vasodilation in aorta andmesenteric arteries from DSS rats. Concentration-response curves for solvent, OA, Me-
OA, and Br-OA in endothelium-intact mesenteric arteries [A, B] or aortic rings [C, D] isolated from DSS rats, pre-contracted with sub-maximal concentration of
PE (5 μM) [A, C] and KCl (50 mM) [B, D]. The values shown are means ± SEM (n = 7). * p < 0.001 vs control, # vs Br-OA.
doi:10.1371/journal.pone.0147395.g003
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absence of a change in heart rate, a decrease of cardiac output and MAP can be brought about
by a change in stroke volume. Such a decrease of stroke volume is unlikely because OA and
derivatives did not cause any negative inotropic effect.
In cells isolated from DSS rats the time to peak and relaxation time was higher than that of
cells from normotensive rats. Cardiac hypertrophy and heart failure caused by high blood pres-
sure reduce the ability of Ca2+ to trigger calcium release from the sarcoplasmic reticulum [17].
Fig 4. Role of the endothelium in response to Br-OA.Concentration-response curves for solvent and Br-OA in mesenteric arteries (A) and aortic rings (B)
isolated fromWistar rats pre-contracted with PE (5 μM). Curves were obtained in endothelium-denuded and intact arteries. Some endothelium-intact vessels
were incubated in the presence of INDO (10 μM) only or in combination with L-NoArg (100 μM) prior to addition of the drug. Values shown are means ± SEM
(n = 7). * p < 0.001 vs control, # vs intact endothelium.
doi:10.1371/journal.pone.0147395.g004
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This, in addition to the decreased sarcoplasmic reticulum Ca2+ uptake [18] may explain the
delayed time-to-peak and relaxation in cardiomyocytes from DSS rats. OA and derivatives had
no apparent effect on shortening in these animals, indicating that the mechanism underlying
the OA and derivatives-induced positive inotropic effect in Wistar rats is deficient in DSS ani-
mals. The mechanism underlying this positive inotropic effect was not clarified. We did not
observe any increase of L-type Ca2+ currents. The experiments on ICa were carried out at room
temperature, using cardiomyocytes dialyzed under whole-cell patch-clamp conditions.
Fig 5. Role of K+ channels in response to Br-OA.Concentration-response curves for solvent and Br-OA in denudedmesenteric arteries (A) and aortic
rings (B) isolated fromWistar rats pre-contracted with PE (5 μM). Denuded arteries were incubated in the presence of Gli (5 mM), 4-AP (1 mM) or
combination of the two inhibitors prior to the addition of the drug. Values shown are means ± SEM (n = 7). * p < 0.001 vs control, # vs Br-OA.
doi:10.1371/journal.pone.0147395.g005
Vascular and Cardiac Effects of Oleanolic Acid and Its Synthetic Oleanane Derivatives
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Additional studies using cells with preserved intracellular medium (under perforated patch
conditions) and at 37°C are needed before completely excluding a mechanism involving L-type
Ca2+ currents. In any case, our study suggests that a negative inotropic action, resulting in a
decrease of stroke volume, is excluded as a mechanism for the hypotensive action of OA and
derivatives. On the other hand, increased cardiomyocyte contractility implies an increase in
cardiac output, an effect which may be beneficial for a drug which causes natriuresis and
vasodilation.
Fig 6. Implication of prostanoids and K+ channels in response to Br-OA. Concentration-response curves for solvent and Br-OA in intact mesenteric
arteries (A) and aortic rings (B) isolated fromWistar rats pre-contracted with PE (5 μM). Curves in intact arteries incubated in the presence of INDO (10 μM)
and Gli (5 mM) or 4-AP (1 mM) and combination of the three inhibitors prior to the addition of the drug. Values shown are means ± SEM (n = 7). * p < 0.001 vs
control, # vs Br-OA.
doi:10.1371/journal.pone.0147395.g006
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The relaxation evoked by OA and derivatives was only partially inhibited in endothelium-
denuded vascular rings. This demonstrates that in our experimental setting the relaxation
involves both endothelium-dependent and independent mechanisms. Other reports suggest
that OA-induced relaxation is nearly fully endothelium-dependent and is associated with an
increased production of NO since relaxation was marginal in endothelium-denuded vessels
and it could be abrogated by NO synthase inhibitors or by NO scavengers [19]. Our results are
thus in contradiction with these previous findings, despite the fact that the various studies used
the same types of vessels (aorta and mesenteric arteries) from the same species (rat). There is
no clear explanation for this discrepancy. However, the same research groups also reported
substantial (~34%) endothelium-resistant relaxation [14, 20]. One possible reason for the dif-
ference might be due to the fact that in our study we tested the relaxation in PE-precontracted
vessels. PE was also the agonist used to contract the vessels in the above-mentioned studies
which also reported substantial endothelium-resistant relaxation [14, 20]. This is in contrast
with the studies where the vessels were precontracted with norepinephrine [19]. Previous studies
have noted that vascular effects of norepinephrine may not only implicate the effects on alpha-
adrenergic receptors, but also effects due to beta-adrenergic receptors and in addition effects due
to non-adrenergic (e.g. dopaminergic) receptors. Therefore, despite the fact that the use of nor-
epinephrine is a better mimic of the physiological conditions, phenylephrine might be more
appropriate when deciphering the mechanisms involved in drug action [21]. Noteworthy, our
results demonstrate that the endothelium-dependent fraction of the relaxation to OA and deriva-
tives is abrogated in the presence of COX inhibitor attesting the implication of a prostanoid-
dependent pathway. Our results corroborate previous studies [22] suggesting that OA promotes
prostaglandin I2 release from vascular smooth muscle cells albeit in a different time-scale.
Pathways underlying the endothelium-independent relaxation evoked by OA and derivatives
may implicate the opening of the K+ channels. Therefore, we tested this hypothesis in denuded
vessels incubated in the presence of blockers of different K+ channels types (Gli for ATP-depen-
dent K+ channels and 4-AP for voltage-activated K+ channels). Either inhibitor when applied
alone blunted part of the relaxation evoked by OA and derivatives. The effects of both inhibitors
were additive and their simultaneous application allowed a complete blockade of the relaxation
to OA, Br-OA andMe-OA, indicating that ATP-dependent and voltage-activated K+ channel
opening in vascular smooth muscle mediate the endothelium independent relaxation.
The present study tested whether two synthetic derivatives of OA display effects similar to
those of the parent compound. Interestingly, the maximum relaxation evoked by one of the
derivatives, Br-OA, was significantly larger in the mesenteric vessels although these differences
were not observed in the aorta. The difference seems to be largely due to the endothelium-inde-
pendent component but the mechanism underlying the larger efficacy of Br-OA is not known.
We speculate that this variation in relaxation profiles of these compounds is probably due to
differences in the effects on receptors or effectors (e.g. channels) present.
The OA or derivatives-induced vasodilatation is expected to result in the decrease of total
peripheral resistance which could be implicated in the blood pressure lowering effect of these
triterpenes. However, in vivo studies indicate that OA, Br-OA or Me-OA acutely decrease
blood pressure to a similar extent [8]. A similar hypotensive effect is not expected if Br-OA is
more efficacious at inducing the vasodilatatory action as suggested by the present study. Addi-
tional factors may contribute to or interfere with the vasodilatatory action. We speculate that
the previously reported improved Na+ elimination caused by these compounds could interact
with these effects on vascular function. Natriuresis without increased diuresis as was obtained
in our in vivo studies [8] is expected to induce a decrease in extracellular Na+ concentration
which can affect transmembrane Na+ gradients and influence the activity of the Na+-Ca2+
exchanger, resulting in changed Ca2+ movements via this pathway. The resulting changes in
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intracellularly available Ca2+ could influence relaxation and hence affect the other mechanisms
that decrease vascular resistance.
In conclusion, the present study provides evidence that OA, Me-OA and Br-OA possess
vasodilatory actions mediated in part by the endothelium-dependent COX/prostanoids path-
way, but also in part by endothelium-independent opening of ATP-dependent and voltage-
activated K+ channels. It sheds further light on possible mechanisms for the antihypertensive
effects of OA and related synthetic oleanane derivatives, which may involve a decrease in vas-
cular resistance.
Supporting Information
S1 Fig. Role of the endothelium in the response to OA. Concentration-response curves for
solvent and OA in mesenteric arteries (A) and aortic rings (B) isolated fromWistar rats pre-
contracted with PE (5 μM). Curves were obtained in endothelium-denuded and intact arteries.
Some endothelium-intact vessels were incubated in the presence of INDO (10 μM) only or in
combination with L-NoArg (100 μM) prior to addition of the drug. Values shown are
means ± SEM (n = 7).  p< 0.001 vs control, # p< 0.001 vs cells from normotensive Wistar
rats.
(TIF)
S2 Fig. Role of the endothelium in the response to Me-OA. Concentration-response curves
for solvent and Me-OA in mesenteric arteries (A) and aortic rings (B) isolated fromWistar rats
pre-contracted with PE (5 μM). Curves were obtained in endothelium-denuded and intact
arteries. Some endothelium-intact vessels were incubated in the presence of INDO (10 μM)
only or in combination with L-NoArg (100 μM) prior to addition of the drug. Values shown
are means ± SEM (n = 7).  p< 0.001 vs control.
(TIF)
S3 Fig. Role of K+ channels in the response to OA. Concentration-response curves for solvent
and OA in denuded mesenteric arteries (A) and aortic rings (B) isolated fromWistar rats pre-
contracted with PE (5 μM). Denuded arteries were incubated in the presence of Gli (5 mM),
4-AP (1 mM) or combination of the two inhibitors prior to the addition of the drug. Values
shown are means ± SEM (n = 7).  p< 0.001 vs control.
(TIF)
S4 Fig. Role of K+ channels in the response to Me-OA. Concentration-response curves for
solvent and Me-OA in denuded mesenteric arteries (A) and aortic rings (B) isolated fromWis-
tar rats pre-contracted with PE (5 μM). Denuded arteries were incubated in the presence of Gli
(5 mM), 4-AP (1 mM) or combination of the two inhibitors prior to the addition of the drug.
Values shown are means ± SEM (n = 7).  p< 0.001 vs control.
(TIF)
S5 Fig. Implication of prostanoids and K+ channels in the response to OA. Concentration-
response curves for solvent and OA in intact mesenteric arteries (A) and aortic rings (B) iso-
lated fromWistar rats pre-contracted with PE (5 μM). Curves in intact arteries incubated in
the presence of INDO (10 μM) and Gli (5 mM) or 4-AP (1 mM) and combination of the
three inhibitors prior to the addition of the drug. Values shown are means ± SEM (n = 7).
 p< 0.001 vs control.
(TIF)
S6 Fig. Implication of prostanoids and K+ channels in the response to Me-OA. Concentra-
tion-response curves for solvent and Me-OA in intact mesenteric arteries (A) and aortic rings
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(B) isolated fromWistar rats pre-contracted with PE (5 μM). Curves in intact arteries incu-
bated in the presence of INDO (10 μM) and Gli (5 mM) or 4-AP (1 mM) and combination
of the three inhibitors prior to the addition of the drug. Values shown are means ± SEM
(n = 7).  p< 0.001 vs control.
(TIF)
S1 Table. Role of endothelium in response to OA, Me-OA and Br-OA. Preliminary concen-
tration-responses for OA, Me-OA, and Br-OA (30 μM) in endothelium-intact mesenteric
arteries or aortic rings isolated fromWistar rats, pre-contracted with sub-maximal concentra-
tion of PE (5 μM). Vessels were incubated in the presence of L-NoArg (100 μM) prior to addi-
tion of the drug. The values shown are means ± SEM (n = 6).
(TIF)
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